Page last updated: 2024-12-05
2-methoxyethanol acetate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 8054 |
| SCHEMBL ID | 24200 |
| SCHEMBL ID | 8999584 |
| MeSH ID | M0131458 |
Synonyms (85)
| Synonym |
|---|
| ethanol, methoxy-, acetate |
| acetic acid, 2-methoxyethyl ester |
| .beta.-methoxyethyl acetate |
| 2-methoxyethyl acetate |
| ethanol, 2-methoxy-, acetate |
| inchi=1/c5h10o3/c1-5(6)8-4-3-7-2/h3-4h2,1-2h |
| methylglycolacetate |
| glycol monomethyl ether acetate |
| 2-metossietilacetato [italian] |
| methyl glycol acetate |
| 2-methoxyethylester kyseliny octove [czech] |
| methylglykolacetat [german] |
| methyl cellosolye acetaat [dutch] |
| hsdb 156 |
| methyl glycol monoacetate |
| egmea |
| ethylene glycol acetate monomethyl ether |
| acetyl methyl cellosolve |
| einecs 203-772-9 |
| diethylene glycol methyl ether acetate |
| methylcellosolveacetate |
| ethylene glycol monomethyl ether monoacetate |
| aethylenglykolmethylaetheracetat [german] |
| acetic acid 2-methoxyethyl ester |
| un1189 |
| ethylene glycol monomethyl ether acetate |
| beta-methoxyethyl acetate |
| 2-methoxyaethylacetat [german] |
| 2-methoxy-ethyl acetaat [dutch] |
| ethylene glycol methyl ether acetate |
| acetate de methyle glycol [french] |
| ccris 5832 |
| methylcelosolvacetat [czech] |
| acetato di metil cellosolve [italian] |
| ethylene glycol methyl acetate |
| 2-methyoxyethylacetate |
| methyl cellosolve acetate |
| 2-methoxyethanol, acetate |
| 2-methoxyethanol acetate |
| 2-methoxyethyle, acetate de [french] |
| brn 1700761 |
| mecsac |
| acetate de l'ether monomethylique de l'ethylene-glycol [french] |
| ai3-11272 |
| 110-49-6 |
| M0113 |
| AKOS006229757 |
| 2-metossietilacetato |
| acetate de methyle glycol |
| 2-methoxyaethylacetat |
| acetate de l'ether monomethylique de l'ethylene-glycol |
| methyl cellosolye acetaat |
| methylcelosolvacetat |
| ethanol, 2-methoxy-, 1-acetate |
| 2-methoxyethylester kyseliny octove |
| unii-i62493e04o |
| acetato di metil cellosolve |
| 2-methoxy-ethyl acetaat |
| aethylenglykolmethylaetheracetat |
| ethylene glycol monomethyl ether acetate [un1189] [flammable liquid] |
| i62493e04o , |
| methylglykolacetat |
| 2-methoxyethyle, acetate de |
| 1-acetoxy-2-methoxyethane |
| FT-0626335 |
| methoxyethanol acetate |
| hisolve mc acetate |
| 2-methoxyethyl acetate [mi] |
| methoxyethanol acetate [inci] |
| SCHEMBL24200 |
| methoxyethyl acetate |
| SCHEMBL8999584 |
| ch3c(o)o(ch2)2och3 |
| un 1189 |
| glycol ether em acetate |
| 2-methoxyethyl ester of acetic acid |
| W-109406 |
| DTXSID2025553 |
| mfcd00008719 |
| 2-methoxyethyl acetate, reagent grade, 98% |
| 2-methoxyethyl acetate, for hplc, >=99% |
| acetic acid 2-methoxy-ethyl ester |
| Q2415195 |
| ?2-methoxyethyl acetate |
| 35126-86-4 |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral dosing of adult male F344 rats with the glycol ether 2-methoxyethanol (ME) or its principal metabolite 2-methoxyacetic acid (MAA) results in the suppression of the primary plaque-forming cell (PFC) response to trinitrophenyl-lipopolysaccharide (TNP-LPS)." | ( Comparative immunosuppression of various glycol ethers orally administered to Fischer 344 rats. Andrews, DL; Copeland, CB; Luebke, RW; Riddle, MM; Smialowicz, RJ; Williams, WC, 1992) | 0.28 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.02
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.02) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (11.11%) | 6.00% |
| Case Studies | 1 (11.11%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (77.78%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||